Mankind Pharma inks pact with Innovent for immunotherapy drug in India
Mankind Pharma Ltd and Innovent Biologics on Thursday announced a partnership to exclusively license and commercialise innovative immunotherapy drug Sintilimab, used in the treatment of cancer, in the Indian market.…
100 specialists set up Immuno-Oncological Society to outline treatment standards
An initiative by IIT-Bombay may help decrease the cost of a sort of immunotherapy used to treat blood tumor to a tenth of that in the US. Dr. Rahul Purwar…